25Jan
Financial Daily Dose 1.25.2021 | Top Story: Merck Abandons Covid Vaccine Effort Over Ineffective Results
U.S. drug giant Merck is shuttering its coronavirus vaccine development “after early trial data showed [its pair of vaccines] failed to generate immune responses comparable to natural infection or existing vaccines.”...
By:
Robins Kaplan LLP
Related
On Tuesday, April 7, we issued an alert in connection with New York Governor Andrew M. Cuomo’s Exec...
Read More >
In a major shift (and with antitrust regulators breathing down its neck), Apple is halving the App S...
Read More >
AIFMD review: European Commission consultation - The European Commission has launched a consultatio...
Read More >
In 2017, the IRS significantly limited the ability of plan sponsors to request a determination lette...
Read More >
Hot on the heels of recent updates to the DIFC employment law, DIFC Employment Law No. 2 of 2019, th...
Read More >
In this episode of Trekking Through Compliance, we consider the episode Spock’s Brain which aired o...
Read More >